Another update by Incannex on the NASDAQ tonight.
Potentially a very big market disruptor arriving.
RESMED should take them out soon.
Short Summary Below.
This trial is significant as it follows a successful Phase 2A study that showed a greater than 50% reduction in the apnea hypopnea index (AHI) at low doses, with 25% of patients achieving over 80% reduction.
The trial will span 52 weeks, involving 560 patients across the US, EU, and UK, and aims to provide an alternative to CPAP machines which many patients find intolerable.
www.incannex.com
- Forums
- ASX - By Stock
- Takeover Target Potential?
Another update by Incannex on the NASDAQ tonight.Potentially a...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$30.50 |
Change
-0.140(0.46%) |
Mkt cap ! $19.32B |
Open | High | Low | Value | Volume |
$30.25 | $30.50 | $30.20 | $41.34M | 1.359M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2645 | $30.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$30.52 | 2677 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2645 | 30.500 |
1 | 2596 | 30.480 |
1 | 2721 | 30.470 |
1 | 2509 | 30.460 |
1 | 2582 | 30.450 |
Price($) | Vol. | No. |
---|---|---|
30.520 | 733 | 2 |
30.540 | 10000 | 1 |
30.600 | 1521 | 2 |
30.620 | 9295 | 1 |
30.640 | 9295 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |